Kachnic study: Dose-painted IMRT shows fewer significant side effects

A phase II Radiation Therapy Oncology Group (RTOG) trial showed that combining chemotherapy with intensity-modulated radiation therapy (IMRT) is just as effective after two years in treating anal cancer as chemotherapy and conventionally delivered radiation therapy, but with fewer significant side effects. Radiation therapy with concurrent 5-fluorouracil and mitomycin-C chemotherapy is the standard of care […]

CReM Seminar: Regulation of Stem Cell Fate, February 15

Join the Center for Regenerative Medicine (CReM) on Tuesday, February 15 as it hosts Dr. Helen M. Blau, the Donald E. and Delia B. Baxter Professor in the Department of Molecular Pharmocology at the Stanford University School of Medicine. Dr. Blau is also Director of the Baxter Laboratory for Stem Cell Biology in the Department […]

Drugs for Hair Loss and Benign Prostatic Hyperplasmia May Result in Loss of Libido, Erectile Dysfunction in Men

Researchers from Boston University School of Medicine (BUSM), in collaboration with colleagues at Lahey Clinic and from Denmark and Germany, have found that 5a-reductase inhibitors (5a-RIs), while improving urinary symptoms in patients with benign prostatic hyperplasia (BPH) and possible hair loss prevention, produces significant adverse effects in some individuals including loss of libido, erectile dysfunction […]

Rafael Ortega to become BUSM Associate Dean for Diversity and Multicultural Affairs

Rafael Ortega, MD, Professor of Anesthesiology, will serve as Associate Dean for Diversity and Multicultural Affairs as of February 1, 2011. Dr. Ortega has been an active member of the BUMC community for 25 years. He joined BUSM as Anesthesiology Medical Student Coordinator in 1986 and in 2007 was named Professor of Anesthesiology. He has been Vice Chair of the Department of Anesthesiology since 1998.

Murphy Honored by American Society of Hematology

BUSM Assistant Professor of Medicine George J. Murphy, PhD, has been named an American Society of Hematology (ASH) 2011 Scholar Award recipient, in the category of Basic Research Junior Faculty. The program is designed to support hematologists who have chosen a career in research by providing partial salary or other support during the critical period […]

Rose Measures Quality of Care in Oral Anticoagulation

Researchers from Boston University School of Medicine (BUSM) and the Bedford VA Medical Center believe that risk-adjusted percent time in therapeutic range (TTR) should be used as part of an effort to improve anticoagulation control and thus improve patient outcomes. These findings appear in this month’s issue of Circulation: Cardiovascular Quality and Outcomes. Oral anticoagulation […]